Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Analgesic Clinical Trial

Official title:
Randomized,Fully-replicated,Single Oral Dose,Open-label,Crossover BE Study to Compare Diclofenac Potassium Coated Tablet (50 mg Diclofenac Potassium) Versus Cataflam® 50 Coated Tablet (50 mg Diclofenac Potassium) in Healthy Subjects in Fasting State

Status Completed

Clinical Trial Summary

Randomized, four-way, four-period, fully-replicated, single oral dose, open-label, crossover, bioequivalence study to compare Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium) versus Cataflam® 50 coated tablet (50 mg Diclofenac Potassium), in healthy subjects under fasting condition

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Analgesic

Clinical Trial Details

NCT number	NCT05082662
Study type	Interventional
Source	Humanis Saglik Anonim Sirketi
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 25, 2020
Completion date	September 16, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02792972` - Antiseptic and Analgesic Action Acmella Oleracea Skin: Randomized Clinical Trial	N/A
Recruiting	`NCT05564819` - Efficacy and Safety of Acetaminophen in Postoperative Pain Management of Infants	Phase 1
Completed	`NCT03943199` - Comparison of Lysine Clonixinate, Ketorolac and Metamizole Sodium in Scorpion Stings	N/A
Recruiting	`NCT04429282` - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.	Phase 3
Completed	`NCT03620136` - Comparison of Two Techniques of Locoregional Analgesia in Total Knee Prosthesis Surgery : Block to the Adductor Channel Versus Peri-articular Local Infiltrations	Phase 3